Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Alzheimer's
  • # DNA
  • # Hoffmann-La Roche
  • # Diabetes
  • linkedin
  • facebook
  • instagram
  • twitter
  • youtube
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

GSK Released EMBRACE a Phase 2b Clinical Trial Data of an Investigational Broadly Neutralising Antibody for HIV

18 March 2025

Johnson & Johnson Launches MENTOR™ MemoryGel™ Breast Implants for Reconstruction Patients

14 May 2025

GSK Announces Early Discontinuation of Phase III PIVOT-PO Study for Tebipenem HBr Due to Positive Efficacy Results

29 May 2025

FDA-approved epilepsy drug prevents brain tumors in mice with NF1

18 April 2024

DNA preserved in an amber-like polymer

15 June 2024

Glycolysis – Pathway and Process Overview

22 October 2024

Eli Lilly Responds to EMA’s Donanemab Marketing Authorization Rejection

29 March 2025

New regenerative medicine research could revolutionize the treatment of type 1 diabetes and open the door to treating autoimmune diseases and cancer.

26 November 2024

Amgen’s IMDELLTRA® Phase 3 Trials Demonstrated Superior Overall Survival in Small Cell Lung Cancer

12 April 2025

Researchers Find Possible Connections Between Skin Ageing and Microbiome

15 January 2024

First person who received the genetically modified pig kidney died after two months

12 May 2024

Researchers have developed a groundbreaking method for the scalable synthesis of Withanolides, which inhibits cancer growth

1 July 2024

Nasal Spray

Mass General Brigham’s Breakthrough Gene Therapy Through Nasal Spray Shows Promising Results for Lung Diseases
Biotechnology Gene Therapy Research

Mass General Brigham’s Breakthrough Gene Therapy Through Nasal Spray Shows Promising Results for Lung Diseases

Ajmal Aseem 27 May 2025

Researchers at Mass General Brigham have developed a promising nasal spray for gene therapy, aiming to deliver treatments directly to the lungs. This innovation could offer a less invasive and more effective approach for genetic lung diseases like cystic fibrosis.

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • Sartorius is Hiring a Process Technology Engineer in Bengaluru, India – May, 2025
  • Cytiva Hiring a Logistics Specialist in Singapore – May 2025
  • AstraZeneca is Hiring an AI Engineer – Lead Consultant in Chennai, India – May 2025
  • Schrödinger is Hiring a Quality Assurance Associate – Hyderabad, India – May 2025
  • Roche Hiring Veeva Vault Business Systems Analysis Expert – Pune, India
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy